Join us for a Werfen Educational Event in Louisville, KY

Date and Time

April 3, 2025
11:30 AM - 3:45 PM ET
*Lunch served at 11:45 AM ET

Location

Louisville Marriott Downtown
280 W Jefferson Street
Louisville, KY 40202

Room: Filly-Thoroughbred

Program Overview

Preanalytical errors account for 70% of all laboratory diagnostic errors, compromising accuracy in blood gas testing.¹ Hemolysis is the #1 source of preanalytical errors and can impact potassium results—potentially leading to inappropriate or delayed patient treatment, unnecessary sample recollection, inefficient staff/nursing time and high costs^.2–8

Our speakers will discuss preanalytical challenges, including hemolysis errors, as well as a new solution for managing hemolysis errors at the point of care.

Objectives

Identify preanalytical factors in blood gas testing
Review challenges in current practices for managing hemolysis at the point of care
Learn about a new technology with the ability to detect hemolysis at the point of care

Credits

Attendees earn 1.0 contact hours (CE credit) offered through P.A.C.E.^®

Werfen is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. Program.

Registration required.

Register for your spot at the Louisville educational event

Featured Speakers

Christopher Farnsworth, PhD

Associate Professor, Dept. of Pathology and Immunology
Washington University School of Medicine
Medical Director, Clinical Chemistry POCT
St. Louis, MO

Xander van Wijk, PhD, DABCC, FADLM

Clinical Chemistry Director
Associate Clinical Professor
UCSF Health
San Francisco, CA

Plebani M. Quality indicators to detect pre-analytical errors in laboratory testing. Clin Biochem Rev. 2012;33(3):85-88.
Lippi G, von Meyer A, Cadamuro J, Simundic A-M. Blood sample quality. Diagnosis. 2018;6(1):25–31. doi:10.1515/dx-2018-0018.
O’Hara M, Wheatley EG, Kazmierczak SC. The impact of undetected in vitro hemolysis or sample contamination on patient care and outcomes in point-of-care testing: a retrospective study. J Appl Lab Med. 2020;5(2):332–341. doi:10.1093/jalm/jfz020.
O’Hara M, Wheatley EG, Kazmierczak SC. The impact of undetected in vitro hemolysis or sample contamination on patient care and outcomes in point-of-care testing: a retrospective study. J Appl Lab Med. 2020;5(2):332-341. doi:10.1093/jalm/jfz020.
Phelan MP, Ramos C, Walker LE, et al. The hidden cost of hemolyzed blood samples in the emergency department. J Appl Lab Med. 2021;6(6):1607–1610. doi:10.1093/jalm/jfab035.
Phelan MP, Hustey FM, Good DM, Reineks EZ. Seeing red: blood sample hemolysis is associated with prolonged emergency department throughput. J Appl Lab Med. 2020;5(4):732–737. doi:10.1093/jalm/jfaa073.
Wilson M, Adelman S, Maitre JB, et al. Accuracy of hemolyzed potassium levels in the emergency department. West J Emerg Med. 2020;21(6):272–275. doi:10.5811/westjem.2020.8.46812.
Milutinović D, Andrijević I, Ličina M, Andrijević L. Confidence level in venipuncture and knowledge on causes of in vitro hemolysis among healthcare professionals. Biochem Med. 2015;25(3):401–409. doi:10.11613/BM.2015.040.

JOIN US FOR AN EDUCATIONAL EVENT

Enhancing Patient Care through Preanalytical Best Pracitces and Hemolysis Detection

April 3, 2025 | Louisville, KY

In-Booth Demonstrations

Industry Workshop

Challenges of hemolysis and K+ management